Pyrrolidinium fullerene induces apoptosis of cells transformed by the JAK2 mutant.
Pyrrolidinium fullerene inhibits the ASK1-MKK4/7-JNK pathway.
Introduction of butyl group improves the ability of fullerene to induce apoptosis.
Introduction of butyl group to fullerene potently inhibits the ASK1-MKK4/7-JNK pathway.